United Kingdom set to approve Pfizer-BioNTech coronavirus vaccine from December 7 - FT

Govt-19 WHO needs 'more than news' on Oxford  Astrogenogen vaccine test | UK News

There were also some concerns that the vaccine would not be as effective for the elderly.

Fearne told MaltaToday in an interview published today that Malta has half-a-million coronavirus vaccine doses ordered from Pfizer and the first batch could be expected to arrive here in January.

"Britain has secured two million doses of Moderna Inc's vaccine candidate, to be available in Europe as early as the spring", the government said on Sunday, in addition to the 5 million doses it secured from the US company two weeks ago.

It has secured 100 million doses of the vaccine developed by AstraZeneca and Oxford University and has targeted a rollout to begin before Christmas. Interim data is reported from the last-stage trail of Moderna's experimental vaccine is 94.5% effective in preventing Covid-19.

Pfizer was the first of three - so far - pharmaceutical companies to publicize the results of its vaccine's phase 3 trial efficacy. Overall, it has access to 357 million doses of vaccines from seven developers, according to government statement.

Health Secretary Matt Hancock said: "Every week we get more positive news about the batch of vaccines in development, and thanks to the work of our staff, the United Kingdom has already ordered hundreds of millions of doses from those companies that are more advanced in their work". Each person requires two doses of the vaccine to be treated.

"The UK was one of the first countries in Europe to sign a deal with Moderna, and I'm delighted we have been able to secure a further 2 million doses of their promising candidate for the British public", Business Secretary Alok Sharma said as quoted in the government release.

"A big responsibility and a big operational challenge but we are absolutely committed to ensuring that vaccines can be implemented quickly to save lives and livelihoods". We are also working at pace to prepare for the delivery of any potential COVID-19 vaccination programme as quickly as possible.

Once they have thoroughly reviewed the data, the MHRA will seek advice from the government's independent advisory body, the Commission on Human Medicines.

Related:

Comments


Other news